Navigation Links
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/12/2009

d quarter 2009 financial results. Telephone numbers for the live conference call are 877-874-1589 (U.S.) or 719-325-4805 (International). The webcast can be accessed on the Investors page of the Transcept website at www.transcept.com and will be available for replay until close of business on November 27, 2009. A playback of the call will be available through November 27, 2009 by dialing 888-203-1112 (U.S.) or 719-457-0820 (International), replay passcode: 2918743.

About Intermezzo®

Intermezzo® (zolpidem tartrate sublingual tablet), the lead product candidate at Transcept, has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. Intermezzo® is a sublingual low dose formulation of zolpidem, the active agent most commonly prescribed in the United States for the treatment of insomnia. Intermezzo® uses approximately one-quarter to one-third of the dose of active drug contained in currently marketed zolpidem-based sleep aids, in a formulation designed to promote rapid sublingual absorption.

Two Phase 3 clinical studies evaluated 376 patients receiving either Intermezzo® or placebo. In the first study, a sleep laboratory trial using an objective polysomnographic endpoint, Intermezzo® demonstrated a statistically significant decrease versus placebo in the time it took patients to return to sleep as measured by Latency to Persistent Sleep. In the second study, an outpatient trial, Intermezzo® demonstrated a statistically significant decrease in Latency to Sleep Onset, a subjective patient reported endpoint. The most common adverse event seen in these trials was headache (2.7 percent active versus 1.4 percent placebo in the outpatient study).

In Septem
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
4. Transcept Pharmaceuticals to Report First Quarter 2009 Results
5. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
6. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
8. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
9. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
10. Endo Pharmaceuticals and LecTec Settle Patent Dispute
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Critical Process Filtration, ... , today announces the expansion of their Technical ... Process Filtration now offers customers and potential customers ... to filter failure analyses (even for competitor filters) ... their hallmark services of system benchmarking and cost/performance ...
(Date:8/28/2014)... -- Rx Safes, Inc., the manufacturer of fingerprint recognition home ... new war on drugs to reduce prescription drug abuse, ... than 2,500 children a day experiment with prescription drugs ... accessed from unsecured medicine cabinets, closets and drawers.  While law ... Safes will address the new age drug dealer in ...
(Date:8/28/2014)... , Californie, 28 août 2014 ... annoncé aujourd,hui le début des inclusions ... étude  d,exemption des dispositifs expérimentaux (ou ... à évaluer l,innocuité et l,efficacité du ... Le docteur Adam Arthur , ...
Breaking Medicine Technology:Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support 2Rx Safes, Inc. Announces New War On Drugs 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4
... 1, 2011 Hologic, Inc. (Hologic or ... developer, manufacturer and supplier of premium diagnostics, medical imaging ... needs of women, today announced it has acquired TCT ... in China, including Hologic,s ThinPrep Pap Test, related instruments ...
... Technology makes the PROFIT 200 list for the third ... Technology, headquartered in Toronto, has been included in the ... by PROFIT Magazine. Ranking Canada,s Fastest-Growing Companies by five-year ... successful growth companies. Published in the Summer issue of ...
Cached Medicine Technology:Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 2Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 3Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 4Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 5Claron Technology Makes the PROFIT 200 List for the Third Consecutive Year 2
(Date:8/28/2014)... Commercial growers all over the continent are waitlisted ... grow lights, which perform on par with 1000w HPS at ... lighting needs no cooling equipment and does not overheat the ... Factoring in that they never need bulbs changed, the internal ... year. , For many indoor growers, cooler room temperatures also ...
(Date:8/28/2014)... be given to healthy volunteers in the UK, The ... of an series of safety trials of potential vaccines ... than 1,400 people in the current outbreak in West ... co-developed by the US National Institutes of Health (NIH) ... an international consortium in response to the Ebola epidemic, ...
(Date:8/28/2014)... place glue directly on the nerve stumps, but this ... allows glue to easily invade the nerve ends. Ordinarily, ... insert the nerve ends into the conduit because the ... Liang and co-workers from the General Hospital of Chinese ... and defined the best parameters for its use through ...
(Date:8/28/2014)... of patients with stage III colon cancer had improved ... a new study in Gastroenterology ... Association. , When added to the standard chemotherapy treatment ... overall survival rates for patients with the CpG island ... to 20 percent of colorectal cancers. Patients with CIMP-negative ...
(Date:8/28/2014)... in the study who were on a class of ... as prescribed in the first six months. Patients from ... around the UK involved in the study. , Researchers ... Genomics at The University of Manchester, who led the ... known as ,non-adherence, reduced their effectiveness and may lead ...
Breaking Medicine News(10 mins):Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Arthritis patients failing to take expensive medication, according to new research 2
... Mount Sinai School of Medicine have found that thyroid-stimulating ... gland that regulates endocrine function in the thyroid gland, ... functions. The research suggests that TSH, or drugs that ... possible future treatments for osteoporosis and other conditions involving ...
... , TUESDAY, Sept. 13 (HealthDay News) -- People with ... focusing their training on their small muscles, researchers say. ... flow and improve patients, quality of life, according to the ... print issue of the Journal of the American College ...
... studies have shown that taking the anti-inflammatory drug celecoxib ... to colon cancers, at the cost of increasing the ... was not necessary? Researchers at Winship Cancer Institute ... (Celebrex) pushes cancer cells into suicide, separately from its ...
... TUESDAY, Sept. 13 (HealthDay News) -- It,s well known that ... than whites are, but new research now suggests they also ... blood pressure. The findings, published online and ... that intervening earlier with medication, as well as lifestyle changes, ...
... HealthDay Reporter , MONDAY, Sept. 12 (HealthDay News) ... boost the risk of Alzheimer,s disease by creating more ... directly prove that high cholesterol causes Alzheimer,s disease or ... didn,t find any link between high cholesterol and tangles, ...
... Benefits of Early Diagnosis and Intervention, released today by ... that are effective in the early stages of Alzheimer,s ... started earlier, and that there is a strong economic ... ADI commissioned a team of researchers led ...
Cached Medicine News:Health News:Pituitary hormone TSH found to directly influence bone growth 2Health News:Muscle Training May Benefit Chronic Heart Failure Patients 2Health News:Separating a cancer prevention drug from heart disease risk 2Health News:Blacks Develop High Blood Pressure a Year Ahead of Whites 2Health News:High Cholesterol Might Be Linked to Alzheimer's Disease 2Health News:World Alzheimer's Report 2011: The benefits of early diagnosis and intervention 2Health News:World Alzheimer's Report 2011: The benefits of early diagnosis and intervention 3
... Single use curved circular ... and titanium staples., ,The ... stapler is used throughout the ... of end-to-end, end-to-side and side-to-side ...
... The Scantibodies Calcitonin Immunoassay is a two-site ... calcitonin. Two different goat polyclonal antibodies to ... chromatography to be specific for well-defined regions ... quantitative determination of Calcitonin in human serum. ...
Calcitonin RIA Kit...
... IMAGE1 is the first completely digital camera ... in the field of endoscopic camera systems. ... the first time, facilitates the fully digital ... quality using an A/D converter, as well ...
Medicine Products: